期刊文献+

食品功能性成分降血脂作用机理研究进展 被引量:20

Progress in Research on Hypolipidemic Mechanisms of Functional Food Components
下载PDF
导出
摘要 高脂饮食的摄入打破了体内脂质代谢平衡,是目前高脂血症患者数量急剧增加的原因之一。具有降血脂功效的食品很多,其功能成分主要为膳食纤维、多糖类、多酚类、生物碱类、皂苷等。本文综述了食物中常见的具有降血脂作用成分的功效及其作用机制的最新研究进展,为降血脂研究及功能食品的开发提供参考。 Increased intake of high-fat diets, disturbing the metabolic balance of liposomes in the body, is one of the major reasons for the dramatic increase in the prevalence of hyperlipidemia. On the other hand, many foods exert lipid-lowering effects through their functional components such as dietary fiber, polysaccharides, polyphenols and steroidal saponins and alkaloids. Herein, we review the latest progress in the study of the hypolipidemic effect and mechanisms of functional food components, aiming to provide a reference for future development and utilization of hypolipidemic natural products.
出处 《食品科学》 EI CAS CSCD 北大核心 2016年第5期239-244,共6页 Food Science
基金 国家现代农业(蚕桑)产业技术体系建设专项(CARS-22)
关键词 降血脂 胆固醇 脂肪酸 甘油三酯 hypolipidemic cholesterol fatty acid triglycerides
  • 相关文献

参考文献67

  • 1CHEN Z Y, JIAO R, MA K Y, et al. Cholesterol-lowering nutraceuticals and functional foods[J]. Journal of Agricultural and Food Chemistry, 2008, 56(19): 8761-8773. DOI:10.1021/jf801566r.
  • 2JAIN K S, KATHIRAVAN M K, SOMANI R S, et al. The biology and chemistry of hyperlipidemia[J]. Bioorgannic & Medicnal Chemistry, 2007, 15( 14): 4674-4699. DOI" 10.1016/j.bmc.2007.04.031.
  • 3MELVYN R, ROBERT D B, ROBERT S R. Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events[J]. American Journal of Medicine, 2010, 123(10): 892-898. DOI:lO.lO16/j.amjmed.2010.03.024.
  • 4FIELDING C J, BIST A, FIELDING P E. Intracellular cholesterol transport in synchronized human skin fibroblasts[J]. Biochemistry, 1999, 38 (8): 2506-2513. DOl:10.1021/bi9810120.
  • 5JIA L, BETTERS J L, YU L Q. Niemann-Pick C1-Like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport[J]. Annual Review Physiology, 2011, 73(1): 239-259. DOI:10.1146/annurev- physiol-012110-142233.
  • 6OLIVER W R, SHENK J L, SNAITH M R, et al. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport[J]. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98(9): 5306-5311. DOI: 10.1073/pnas.091021198.
  • 7van der VEEN J N, KRUIT J K, HAVINGA R, et al. Reduced cholesterol absorption upon PPAR delta activation coincides with decreased intestinal expression of NPC1LI[J]. Journal of Lipid Research, 2005, 46(3): 526-534. DOI:10.1194/jlr.M400400-JLR200.
  • 8WANG Y X, ZHANG C L, YU R T, et al. Regulation of muscle fiber type and running endurance by PPAR delta[J]. PLoS Biology, 2004, 2(10): 1532-1539. DOI:10.1371/jourual.pbio.0020294.
  • 9SHAH P K. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease[J]. Europen Heart Journal, 2007, 28(1): 5-12. DOI:10.1093/eurheartj/eh1392.
  • 10EBERLE D, HEGARTY B, BOSSARD P, et al. SREBP transcription factors: master regulators of lipid homeostasis[J]. Biochimie, 2004, 86(11): 839-848. DOI: 10.1016/j.biochi.2004.09.018.

二级参考文献53

共引文献48

同被引文献290

引证文献20

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部